Cellular metabolic responses, determined as the indications of inositol phosphate (IPs) formation, arachidonic acid release and intracellular Ca2+ concentration, to stimulation with prostaglandin F2α (PGF2α) or gonadotropin releasing hormone (GnRH), were studied in monolayer- cultured rat luteal cells which maintained a function of progesterone production and secretion. The results were as follows: 1. In 5 day-old luteal cells, IPs formation, i. e., activation of phospholipase C, was significantly enhanced by stimulation with PGF2α or GnRH. Arachidonic acid release, i. e., activation of phospholipase A2, was also stimulated by these agonists. The agonist stimulation of [14C] glycerollabeled cells induced a marked decrease in the labels of p...
The gonadotropin-releasing hormone (GnRH) controls LH and FSH secretion by membrane receptor interac...
The gonadotropin-releasing hormone (GnRH) controls LH and FSH secretion by membrane receptor interac...
The phospholipase A2 (PLA2) inhibitors, quinacrine, p-bromophenacyl bromide, ONO-RS-082, aristolochi...
Cellular metabolic responses, determined as the indications of inositol phosphate (IPs) formation, a...
Cellular metabolic responses, determined as the indications of inositol phosphate (IPs) formation, a...
The present study was conducted to investigate the hypothesis that membrane phosphoinositide breakdo...
The present study was conducted to investigate the hypothesis that membrane phosphoinositide breakdo...
The effects of prostaglandin F2[alpha] (PGF2[alpha] administration on the utilization of low density...
The possibility that FSH stimulates the phospholipase A(2) (PLA(2)) pathway was studied in cultured ...
Mechanisms of arachidonic acid release from cultured rat luteal cells were studied with special refe...
The effects of prostaglandin F, (PGF 2) administration on the utilization of low density lip~rotein ...
The first step in gonadotropin-releasing hormone (GnRH) action involves the binding of GnRH to a pla...
A number of clonal cell lines derived from a rat pituitary tumour, collectively termed GH cells, hav...
Production of hormones in the ovary is controlled by endocrine, paracrine, autocrine and intracrine ...
Luteal regression is a multistep, prolonged process, and long-term luteal cultures are required for ...
The gonadotropin-releasing hormone (GnRH) controls LH and FSH secretion by membrane receptor interac...
The gonadotropin-releasing hormone (GnRH) controls LH and FSH secretion by membrane receptor interac...
The phospholipase A2 (PLA2) inhibitors, quinacrine, p-bromophenacyl bromide, ONO-RS-082, aristolochi...
Cellular metabolic responses, determined as the indications of inositol phosphate (IPs) formation, a...
Cellular metabolic responses, determined as the indications of inositol phosphate (IPs) formation, a...
The present study was conducted to investigate the hypothesis that membrane phosphoinositide breakdo...
The present study was conducted to investigate the hypothesis that membrane phosphoinositide breakdo...
The effects of prostaglandin F2[alpha] (PGF2[alpha] administration on the utilization of low density...
The possibility that FSH stimulates the phospholipase A(2) (PLA(2)) pathway was studied in cultured ...
Mechanisms of arachidonic acid release from cultured rat luteal cells were studied with special refe...
The effects of prostaglandin F, (PGF 2) administration on the utilization of low density lip~rotein ...
The first step in gonadotropin-releasing hormone (GnRH) action involves the binding of GnRH to a pla...
A number of clonal cell lines derived from a rat pituitary tumour, collectively termed GH cells, hav...
Production of hormones in the ovary is controlled by endocrine, paracrine, autocrine and intracrine ...
Luteal regression is a multistep, prolonged process, and long-term luteal cultures are required for ...
The gonadotropin-releasing hormone (GnRH) controls LH and FSH secretion by membrane receptor interac...
The gonadotropin-releasing hormone (GnRH) controls LH and FSH secretion by membrane receptor interac...
The phospholipase A2 (PLA2) inhibitors, quinacrine, p-bromophenacyl bromide, ONO-RS-082, aristolochi...